Eli Lilly & Co.’s stock was on pace for its worst day in about three years Thursday as investors fretted about intensifying ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock witness a selloff after positive trial data for an oral weight loss drug ...

The selloff in tech stocks that sent the S&P 500 and Nasdaq sinking yesterday continued at midday,. The Dow fell from its all ...

Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the ...

The stock's fall snapped a two-day winning streak.

Eli Lilly (LLY) and Novo Nordisk (NVO) under pressure as Roche (RHHBY) posts early-stage data for oral weight loss drug ...

Shares of Novo Nordisk and Eli Lilly took a hit after Swiss pharma giant Roche posted positive results for its experimental ...

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...

Shares of drugmakers Eli Lilly and Novo Nordisk continued sinking Thursday on concerns their dominance of the booming anti-obesity drug market is under threat. Shares of Eli Lilly have fallen about 10 ...

Eli Lilly's shares plunged 6.9% Thursday, their worst daily performance since March 2021. Emerging weight-loss drugs from ...

Eli Lilly and Company stock is moving lower on Thursday on possible continued weakness after recent weight loss data from ...